It’s a completely defensible position because it has been taken from a completely defensive posture. If your product can’t be guaranteed for purity, even with new and improved testing, you do what you must to mitigate the potential downside while still maintaining brand growth and awareness.
Today, (December 19, 2017) on the same day that twice-banned U.S. sprint star Justin Gatlin was tangentially implicated in an investigative drug sting, Abbott World Marathon Majors announced that Edna Kiplagat of Kenya has been awarded its Series X women’s championship and the $500,000 prize that attends it.
Ms. Kiplagat had originally finished second in the Series X cycle to fellow Kenyan Jemima Sumgong, the 2016 London and Rio Olympic champion. But after the putative champion gave a positive sample for EPO in an out-of-competition test in February 2017, the series title was held up awaiting disposition by Kenyan doping authorities. Today, Ms. Kiplagat, runner up in Chicago 2016 and winner at the Series X closing 2017 Boston Marathon, was officially moved into the top spot as Ms. Sumgong was banned for four years by the Anti Doping Agency of Kenya (ADAK).
Ms. Sumgong’s drug failure marked the fourth time in its ten-cycle history that the Abbott World Marathon Majors has had to disqualify a women’s series winner for a failed a drug test, not the outcome the original five series events had imagined when they banded together in 2006. Continue reading